Current Stage of Interleukin 2 Receptor Targeted Therapy1)
- 1 December 1989
- journal article
- review article
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 93 (02/03) , 114-124
- https://doi.org/10.1055/s-0029-1210844
Abstract
The overview summarizes a new and selective form of immunosuppressive therapy by using anti-Interleukin-2 receptor monoclonal antibodies, which may soon become an important form of recipient treatment in organ/tissue transplantation or/and of patient treatment with autoimmune diseases.Keywords
This publication has 0 references indexed in Scilit: